Sentences with phrase «lymphoma who»

Please schedule a consultation appointment with our Oncology Department if you have a dog with lymphoma who may benefit from this new treatment.

Cats with lymphoma who are not treated with chemotherapy have an average survival time of 4 weeks once the diagnosis has been made.

Cats with intestinal lymphoma who are treated with prednisone alone have a life expectancy of 60 - 90 days.

Should all patients with Hodgkin lymphoma who relapse after autologous SCT be considered for allogeneic SCT?

The trial included 63 patients with histologically confirmed marginal zone lymphoma who had received one or more prior therapy including at least one CD20 monoclonal antibody.

The US Food and Drug Administration (FDA) recently approved the oral Bruton tyrosine kinase (BTK) inhibitor ibrutinib for the treatment of patients with relapsed or refractory marginal zone lymphoma who require systemic therapy and have had at least one prior anti-CD20 therapy.

The US FDA has granted Priority Review designation for tisagenlecleucel (Kymriah) for treatment of adult patients with relapsed or refractory diffuse large B - cell lymphoma who are ineligible for, or have relapsed after, ASCT.

The new indication puts Kymriah in direct competition with Gilead Sciences» Yescarta, which was approved by the U.S. Food and Drug Administration in October for treatment of adults with diffuse large B - cell lymphoma who have failed to respond to other treatments.

Not exact matches

The proposal comes after negotiations between the South Korean firm, workers and their families as well as outside experts over the company's responsibility for the workers, who have attributed illnesses such as lymphoma and leukemia to prolonged exposure to radiation or dangerous chemicals used in Samsung's factories.

Over the next few hours, he'll use the da Vinci to cut out a lymph node from the patient (who suffers from lymphoma) for lab testing.

Seven years ago Fortune wrote an in - depth profile of Blankfein, who just announced he has «highly curable» lymphoma.

MEG TIRRELL, NIGHTLY BUSINESS REPORT CORRESPONDENT: Since they were approved in 2014, drugs that stimulate the immune system have been giving new hope to patients with melanoma, kidney cancer, lymphoma and other cancers, including famously to President Jimmy Carter, who credited the drug called Keytruda with shrinking tumors that had spread to his brain.

Woodruff, who was diagnosed with Non-Hodgkin's Lymphoma in May and began receiving treatment in July, is sitting out the season to battle the disease.

Babies who are raised on commercial formula are 8 times more like to develop leukemia and lymphoma.

Would a doctor who said, «Well, yes, Hodgkin lymphoma is 100 % fatal without treatment and 90 + % survivable with treatment but I'm neutral on the issue of whether people should be treated or not» inspire confidence in that practitioner?

A doctor who presented both the pros and cons of taking chemotherapy for Hodgkin lymphoma but didn't advise you to take the treatment?

Benefits / risks to both mother and baby USA studies: Less sudden Infant Death syndrome in exclusively breastfed babies, less Childhood Lymphoma / Leukemia in children who were breastfed 6 or more months, better bone remineralizaton for mother after weaning in mothers who breastfed than those who didn't.

On Sunday, August 5, 2012, Kerry Kelemen will receive tribute from the Leukemia & Lymphoma Society (LLS) at its annual Rockland County Light the Night Walk Kickoff Party at Rockland Boulders Stadium in Pomona, NY from 1 until 3 p.m. Laurie Walser of Nyack is an honored AML survivor, who will also receive tribute at the event.

Specifically, «The bill expands coverage to volunteer firefighters with at least five years of service who developed lymphoma or leukemia after their service, and coverage for volunteer firefighters with at least 10 years of service who develop stomach, skin, breast, prostate and other reproductive cancers after their service,» according to information from Senator Jacobs» office.

Also benefitting will be The Leukemia & Lymphoma Society's Team in Training Program in memory of Jacquie Hirsch, a Williamsville native who lost her life to A.L.L. (Acute Lymphocytic Leukemia) September 6, 2008.

Badylak used his old connections to help pay his way, setting up a lab in his home to diagnose ferret lymphoma and dog breast cancer for former veterinary classmates who mailed him samples.

She was seriously ill for several years, but no one mentioned that she had lymphoma until shortly before she died — with Allison, who was 11, holding her hand.

Jason Westin, who until recently ran clinical trials testing treatments for lymphoma, hopes to claim the Democratic nomination to challenge the veteran Republican incumbent, John Culberson (TX).

«We found very high response rates to this treatment combination, which has the added benefit of having a much reduced risk of long - term organ damage compared to the highly toxic chemotherapy agents typically used for patients with relapsed Hodgkin lymphoma,» says Dr. Kelly, who is Program Director of the Pediatric Hematology / Oncology Service Line at the Women & Children's Hospital of Buffalo and holds an additional faculty appointment with the University at Buffalo.

There is evidence that people who are physically active have a lower risk of some cancers such as colon and breast cancers, but not many studies have investigated whether being physical active is associated with the risk of non-Hodgkin lymphoma.

Even lymphoma patients who were «bacteria - free» benefited from a three - week course of doxycycline therapy, and showed complete remission of the disease.

A team led by Øystein Fluge and Olav Mella at the Haukeland University Hospital in Bergen, Norway, discovered by chance that rituximab might help people with CFS after seeing symptoms ease in a patient who had both lymphoma and CFS (PLoS One, DOI: 10.1371 / journal.pone.0026358).

Experience with lymphoma patients, who receive a transplant of their own blood or bone cells after radiation to wipe out their cancer, has shown «there's no doubt it helps,» says bone marrow transplant expert Nelson Chao of Duke University in Durham, North Carolina.

The metric showed that by age 50 Hodgkin lymphoma survivors had more than twice as many cardiovascular problems than adults who had not had cancer as children.

Of 17,477 Hodgkin lymphoma cases examined, the researchers identified 89 survivors who later developed stomach cancer.

«Because Hodgkin lymphoma patients commonly receive treatment in their 20s and 30s, many of the stomach cancers arise before age 50, nearly 20 years earlier than is typical for newly diagnosed patients who have never had cancer.

Hodgkin lymphoma survivors who received certain radiation and chemotherapy regimens were at increased risk of subsequently developing stomach cancer, according to a study by scientists at the National Cancer Institute (NCI), part of the National Institutes of Health.

Researchers at Princess Margaret Cancer Centre have confirmed in a screening effectiveness study that early screening with MRIs can reduce breast cancer mortality for female survivors of childhood Hodgkin's lymphoma (HL) who received chest radiation.

In the trial, co-led by Rachael Clark, MD, PhD, associate professor of Dermatology at Harvard Medical School, Alain Rook, MD, professor of Dermatology and director of the Cutaneous Lymphoma Program at Penn Medicine, and Joel M. Gelfand, MD, MSCE, associate professor of Dermatology and medical director of the Clinical Studies Unit at Penn Medicine, twelve patients who had previously undergone an average of six treatments for early stage CTCL were treated with topical resiquimod gel at varying doses and intervals.

For patients who have HIV and Hodgkin lymphoma, treatment can be effective and tolerated, especially when the lymphoma subtype is known, Olszewski said, but doctors should understand that some patients many need extra assistance or attention to ensure they connect with that care.

The researchers, who were funded by Leukemia & Lymphoma Research and Cancer Research UK, have shown that some cancer cells are able to draw monoclonal antibodies inside themselves, making them invisible to immune cells.

Among people in the study who did get lymphoma treatment, HIV - positive people were statistically just as likely to survive as HIV - negative people.

Meanwhile, doctors have had a muddy sense of whether HIV - positive people with Hodgkin lymphoma survive the cancer as well as people who are HIV - negative.

Their team discovered by accident that rituximab might work against CFS after seeing symptoms ease in a patient who had both lymphoma and CFS.

Patients with a history of breast cancer or lymphoma were more than three times as likely to develop heart failure — a condition in which the heart can't pump enough blood to meet the body's needs — compared with a similar group of patients who did not have cancer, according to data being presented at the American College of Cardiology's 67th Annual Scientific Session.

In a study of 30 patients who received CTL019 for three different types of non-Hodgkin lymphoma, the researchers found that 59 percent of patients responded to the therapy (17 of 29, 15 of who experienced complete remissions of their disease).

People with breast cancer or lymphoma were three times as likely to develop heart failure within five years of their cancer diagnosis, and 20 years following cancer treatment were still nearly twice as likely to have been diagnosed with heart failure compared to similar patients who didn't undergo cancer therapy.

Researchers then compared patients in the trial to 151 similar patients who did not have HIV but received the same treatment for their lymphoma using data reported to the Center for International Blood & Marrow Transplant Research (CIBMTR).

As an organization of physicians and scientists who care for desperately ill patients, including those with blood cancers such as leukemia, lymphoma, and myeloma, the American Society of Hematology (ASH) is supportive of efforts to provide insurance parity for all approved evidence - based cancer treatments.

As demonstrated by the breadth of clinical trial involvement shown above, CCIR members are testing the utility of immune checkpoint blockade in lymphoma (shown by Dr. Allison to be effective against melanoma), genetic engineering in cell therapy (e.g., CD19, CXCR2, TGF - β DNR), and TLR agonists or IL - 2 in vaccine formulations as well as some novel combination therapies, such as the infusion of tumor - reactive lymphocytes from HLA - matched donors who were vaccinated with a lymphoma idiotype.

The FDA has approved the CAR T - cell therapy axicabtagene ciloleucel (Yescarta) for the treatment of large B - cell lymphomas in adults who have failed or relapsed after two or more prior treatments.

As many as 30 percent of patients who survive childhood Hodgkin lymphoma develop a secondary cancer after diagnosis, primarily breast cancer, non-Hodgkin lymphoma, thyroid cancer or acute leukemia.

The US Food and Drug Administration (FDA) has granted Priority Review designation for tisagenlecleucel (Kymriah), formerly known as CTL019, for treatment of adult patients with relapsed or refractory diffuse large B - cell lymphoma (DLBCL) who are ineligible for, or have relapsed after, autologous stem cell transplant.

FDA Approved Ibrutinib for Relapsed, Refractory Marginal Zone Lymphoma: Approval for the use of ibrutinib in patients with relapsed or refractory marginal zone lymphoma was granted by the US Food and Drug Administration for those patients who require systemic therapy who were treated with at least one anti-CD20 Lymphoma: Approval for the use of ibrutinib in patients with relapsed or refractory marginal zone lymphoma was granted by the US Food and Drug Administration for those patients who require systemic therapy who were treated with at least one anti-CD20 lymphoma was granted by the US Food and Drug Administration for those patients who require systemic therapy who were treated with at least one anti-CD20 therapy.

We describe a 66 - year - old man with a long - standing history of squamous cell carcinoma of the head and neck region who developed nodular - sclerosing subtype of classical Hodgkin lymphoma and primary cutaneous CD8 - positive, cytotoxic variant of mycosis fungoides over a 1 - year period of time.